Dogwood Therapeutics Financial Overview
Dogwood Therapeutics's market cap is currently $143.88M. The company's EPS TTM is $-8.2; its P/E ratio is -0.16; Dogwood Therapeutics is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is $-0.56. See an overview of income statement, balance sheet, and cash flow financials.
